Rash C - Search Results

1

Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.

Knab B, Rash C, Farrey K, Jani AB. Knab B, et al. Among authors: rash c. Med Dosim. 2006 Winter;31(4):292-7. doi: 10.1016/j.meddos.2006.03.001. Med Dosim. 2006. PMID: 17134669

2

Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques.

Milano MT, Garofalo MC, Chmura SJ, Farrey K, Rash C, Heimann R, Jani AB. Milano MT, et al. Among authors: rash c. Br J Radiol. 2006 Jun;79(942):497-503. doi: 10.1259/bjr/43441736. Br J Radiol. 2006. PMID: 16714752

3

Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.

Liauw SL, Weichselbaum RR, Rash C, Correa D, Al-Hallaq HA, Pelizzari CA, Jani AB. Liauw SL, et al. Among authors: rash c. Technol Cancer Res Treat. 2009 Jun;8(3):201-6. doi: 10.1177/153303460900800304. Technol Cancer Res Treat. 2009. PMID: 19445537 Free article.

4

Intensity-modulated radiation therapy for prostate cancer.

Jani AB, Roeske JC, Rash C. Jani AB, et al. Among authors: rash c. Clin Prostate Cancer. 2003 Sep;2(2):98-105. doi: 10.3816/cgc.2003.n.016. Clin Prostate Cancer. 2003. PMID: 15040870 Review.

5

Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.

Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP, Kwon OH, Jani AB, Heimann R. Milano MT, et al. Among authors: rash c. Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):445-53. doi: 10.1016/j.ijrobp.2003.11.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145161 Clinical Trial.

6

A case study of radiotherapy planning for a bilateral metal hip prosthesis prostate cancer patient.

Su A, Reft C, Rash C, Price J, Jani AB. Su A, et al. Among authors: rash c. Med Dosim. 2005 Fall;30(3):169-75. doi: 10.1016/j.meddos.2005.06.001. Med Dosim. 2005. PMID: 16112469

7

Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.

Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ. Milano MT, et al. Among authors: rash c. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):354-61. doi: 10.1016/j.ijrobp.2005.02.030. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168830

8

Comparison of dose calculated by an intensity modulated radiotherapy treatment planning system and an independent monitor unit verification program.

Haslam JJ, Bonta DV, Lujan AE, Rash C, Jackson W, Roeske JC. Haslam JJ, et al. Among authors: rash c. J Appl Clin Med Phys. 2003 Summer;4(3):224-30. doi: 10.1120/jacmp.v4i3.2519. J Appl Clin Med Phys. 2003. PMID: 12841793 Free PMC article.

9

Eye shielding for patients treated with total body irradiation.

Reft C, Rash C, Dabrowski J, Roeske JC, Hallahan D. Reft C, et al. Among authors: rash c. Med Dosim. 1996 Summer;21(2):73-8. doi: 10.1016/0958-3947(95)02050-0. Med Dosim. 1996. PMID: 8807606

10

Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey.

Pickering E, Viera A, Sung ML, Davidson D, Bailey G, Buchelli M, Jenkins M, Kolakowski J, Maier L, Edelman EJ, Rash CJ. Pickering E, et al. Among authors: rash cj. Addict Sci Clin Pract. 2024 Dec 23;19(1):97. doi: 10.1186/s13722-024-00503-4. Addict Sci Clin Pract. 2024. PMID: 39710733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters